Study of XL092 in Combination With Immuno-Oncology Agents in Subjects With Solid Tumors (STELLAR-002)
NCT 05176483 Brief Summary This is a multicenter Phase 1b, open label,…
Read more arrow_forwardNCT 05176483 Brief Summary This is a multicenter Phase 1b, open label,…
Read more arrow_forwardNCT 05607550 Brief Summary Global, Phase 3, randomized, multicenter, open-label study evaluating…
Read more arrow_forwardNCT 06356129 Brief Summary The purpose of this study is to…
Read more arrow_forwardNCT 03821935 Brief Summary The study will determine the recommended Phase 2…
Read more arrow_forwardNCT 05037760 Brief Summary This is a Phase 2, multicenter, open-label study…
Read more arrow_forwardNCT 05952037 Brief Summary This study will evaluate the safety and efficacy…
Read more arrow_forwardNCT 04581512 Brief Summary A research study looking at a new treatment…
Read more arrow_forwardNCT 04665206 Brief Summary This is an open-label, dose escalation and expansion…
Read more arrow_forwardNCT 05727904 Brief Summary This is a Phase 3, multicenter, open-label, randomized,…
Read more arrow_forwardNCT 05317416 Brief Summary The purpose of this study is to…
Read more arrow_forward